National Institute for Occupational Safety and Health (NIOSH); World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC)
| Published date | 19 August 2019 |
| Citation | 84 FR 42918 |
| Record Number | 2019-17690 |
| Section | Notices |
| Court | Centers For Disease Control And Prevention |
Federal Register, Volume 84 Issue 160 (Monday, August 19, 2019)
[Federal Register Volume 84, Number 160 (Monday, August 19, 2019)]
[Notices]
[Pages 42918-42919]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17690]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health (NIOSH);
World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP STAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
National Institute for Occupational Safety and Health (NIOSH),
announces the following meeting for the World Trade Center Health
Program Scientific/Technical Advisory Committee (WTCHP STAC). This
meeting is open to the public, limited only by the number of telephone
lines. The room will accommodate approximately 100 persons. The public
is also welcome to listen to the meeting by dial-in 1 (800) 988-0212,
the passcode 1440561, and will accommodate up to 50 callers. To view
the web conference, enter the following web address in your web
browser: https://odniosh.adobeconnect.com/wtchpstac19-1/.
DATES: The meeting will be held on September 18, 2019, 10:30 a.m. to
4:00 p.m., EDT.
Public Comment Time and Date: September 18, 2019, 10:45 a.m. to
11:00 a.m., EDT.
Please note that the public comment period ends at the time
indicated above or following the last call for comments, whichever is
earlier. Members of the public who want to comment must sign up by
providing their name to Mia Wallace, Committee Management Specialist,
by phone: (404) 498-2553, email: [email protected], or the addresses
provided below by September 4, 2019. Each commenter will be provided up
to five minutes for comment. A limited number of time slots are
available and will be assigned on a first come-first served basis.
Written comments will also be accepted from those unable to attend the
public session.
ADDRESSES: Jacob J. Javits Federal Building, 26 Federal Plaza, Rooms A/
B, New York, New York 10278.
FOR FURTHER INFORMATION CONTACT: Tania Carre[oacute]n-Valencia, Ph.D.,
Designated Federal Officer, World Trade Center Health Program Associate
Director for Science, 1600 Clifton Rd. NE, MS: R-12, Atlanta, GA 30329-
4027; telephone (513) 841-4515; email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The WTCHP STAC was established by Title I of the James
Zadroga 9/11 Health and Compensation Act of 2010, Public Law 111-347
(January 2, 2011), amended by Public Law 114-113 (Dec. 18, 2015),
adding Title XXXIII to the Public Health Service Act (codified at 42
U.S.C. 300mm to 300mm-61).
Purpose: The purpose of the WTCHP STAC is to review scientific and
medical evidence and to make recommendations to the World Trade Center
(WTC) Program Administrator regarding additional WTC Health Program
eligibility criteria, potential additions to the list of covered WTC-
related health conditions, and research regarding certain health
conditions related to the September 11, 2001 terrorist attacks.
Title XXXIII of the PHS Act established the WTC Health Program
within the Department of Health and Human Services (HHS). The WTC
Health Program provides medical monitoring and treatment benefits to
eligible firefighters and related personnel, law enforcement officers,
and rescue, recovery, and cleanup
[[Page 42919]]
workers who responded to the September 11, 2001, terrorist attacks in
New York City, at the Pentagon, and in Shanksville, Pennsylvania
(responders), and to eligible persons who were present in the dust or
dust cloud on September 11, 2001 or who worked, resided, or attended
school, childcare, or adult daycare in the New York City disaster area
(survivors). Certain specific activities of the WTC Program
Administrator are reserved to the Secretary, HHS, to delegate at his
discretion; other WTC Program Administrator duties not explicitly
reserved to the Secretary, HHS, are assigned to the Director, NIOSH.
The administration of the WTCHP STAC is left to the Director of NIOSH
in his role as WTC Program Administrator. CDC and NIOSH provide
funding, staffing, and administrative support services for the WTCHP
STAC. The charter was reissued on May 12, 2019, and will expire on May
12, 2021.
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to http://www.regulations.gov within 60 days after the meeting. If a person
making a comment gives his or her name, no attempt will be made to
redact that name. NIOSH will take reasonable steps to ensure that
individuals making public comments are aware of the fact that their
comments (including their name, if provided) will appear in a
transcript of the meeting posted on a public website. Such reasonable
steps include a statement read at the start of the meeting stating that
transcripts will be posted and names of speakers will not be redacted.
If, in making a statement, individuals reveal personal information
(e.g., medical information) about themselves, that information will not
usually be redacted. The CDC Freedom of Information Act coordinator
will, however, review such revelations in accordance with the Freedom
of Information Act and, if deemed appropriate, will redact such
information. Disclosures of information concerning third party medical
information will be redacted.
Matters To Be Considered: The agenda will include discussions on
research integration activities that the WTC Health Program is
undertaking, including research evaluation and strategic planning; an
update on the policies and procedures in effect within the WTC Health
Program that are used to determine whether sufficient evidence is
available to support adding a non-cancer condition to the List of WTC-
Related Health Conditions; and an update on the development of the
Inventory of 9/11 Agents that the Program will use for administrative
purposes. Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-17690 Filed 8-16-19; 8:45 am]
BILLING CODE 4163-18-P
